These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25946120)

  • 1. Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission.
    Arora T; Velagapudi V; Pournaras DJ; Welbourn R; le Roux CW; Orešič M; Bäckhed F
    PLoS One; 2015; 10(5):e0126401. PubMed ID: 25946120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y gastric bypass surgery alters serum metabolites and fatty acids in patients with morbid obesity.
    Wijayatunga NN; Sams VG; Dawson JA; Mancini ML; Mancini GJ; Moustaid-Moussa N
    Diabetes Metab Res Rev; 2018 Nov; 34(8):e3045. PubMed ID: 30003682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery.
    Nannipieri M; Mari A; Anselmino M; Baldi S; Barsotti E; Guarino D; Camastra S; Bellini R; Berta RD; Ferrannini E
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1372-9. PubMed ID: 21778221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SURMetaGIT study: Design and rationale for a prospective pan-omics examination of the gastrointestinal response to Roux-en-Y gastric bypass surgery.
    Sala P; Belarmino G; Machado NM; Cardinelli CS; Al Assal K; Silva MM; Fonseca DC; Ishida RK; Santo MA; de Moura EG; Sakai P; Guarda IF; da Silva ID; Rodrigues AS; Pereira CA; Heymsfield S; Doré J; Torrinhas RS; Giannella-Neto D; Waitzberg DL
    J Int Med Res; 2016 Dec; 44(6):1359-1375. PubMed ID: 27834300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.
    Kadera BE; Lum K; Grant J; Pryor AD; Portenier DD; DeMaria EJ
    Surg Obes Relat Dis; 2009; 5(3):305-9. PubMed ID: 19460674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery.
    Mutch DM; Fuhrmann JC; Rein D; Wiemer JC; Bouillot JL; Poitou C; Clément K
    PLoS One; 2009 Nov; 4(11):e7905. PubMed ID: 19936240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes.
    Graessler J; Bornstein TD; Goel D; Bhalla VP; Lohmann T; Wolf T; Koch M; Qin Y; Licinio J; Wong ML; Chavakis T; Xu A; Shevchenko A; Schuhmann K; Schwarz PE; Schulte KM; Patel A; Bornstein SR
    Pharmacogenomics J; 2014 Jun; 14(3):201-7. PubMed ID: 24365785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roux-en-Y gastric bypass surgery, but not calorie restriction, reduces plasma branched-chain amino acids in obese women independent of weight loss or the presence of type 2 diabetes.
    Lips MA; Van Klinken JB; van Harmelen V; Dharuri HK; 't Hoen PA; Laros JF; van Ommen GJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Dane A; Harms A; Vreeken R; Hankemeier T; Smit JW; Pijl H; Willems van Dijk K
    Diabetes Care; 2014 Dec; 37(12):3150-6. PubMed ID: 25315204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced glucose metabolism in cultured human skeletal muscle after Roux-en-Y gastric bypass surgery.
    Nascimento EB; Riedl I; Jiang LQ; Kulkarni SS; Näslund E; Krook A
    Surg Obes Relat Dis; 2015; 11(3):592-601. PubMed ID: 25862179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.
    Jiménez A; Casamitjana R; Flores L; Viaplana J; Corcelles R; Lacy A; Vidal J
    Ann Surg; 2012 Dec; 256(6):1023-9. PubMed ID: 22968072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner.
    Gralka E; Luchinat C; Tenori L; Ernst B; Thurnheer M; Schultes B
    Am J Clin Nutr; 2015 Dec; 102(6):1313-22. PubMed ID: 26581381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study.
    Wickremesekera K; Miller G; Naotunne TD; Knowles G; Stubbs RS
    Obes Surg; 2005 Apr; 15(4):474-81. PubMed ID: 15946424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Omics" Prospective Monitoring of Bariatric Surgery: Roux-En-Y Gastric Bypass Outcomes Using Mixed-Meal Tolerance Test and Time-Resolved (1)H NMR-Based Metabolomics.
    Lopes TI; Geloneze B; Pareja JC; Calixto AR; Ferreira MM; Marsaioli AJ
    OMICS; 2016 Jul; 20(7):415-23. PubMed ID: 27428253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity.
    Zhao L; Ni Y; Yu H; Zhang P; Zhao A; Bao Y; Liu J; Chen T; Xie G; Panee J; Chen W; Rajani C; Wei R; Su M; Jia W; Jia W
    FASEB J; 2017 Apr; 31(4):1449-1460. PubMed ID: 28007782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Systematic Review and Meta-analysis of the Effect of Gastric Bypass Surgery on Plasma Lipid Levels.
    Carswell KA; Belgaumkar AP; Amiel SA; Patel AG
    Obes Surg; 2016 Apr; 26(4):843-55. PubMed ID: 26210195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.